Platelet inhibitory activity, tolerability, and safety of vicagrel, a novel thienopyridine P2Y12 inhibitor

Vicagrel is a new antiplatelet pro-drug based on clopidogrel sulfur lactone metabolites. The purpose of the study was to evaluate the safety, tolerability, and pharmacodynamics (PD) of vicagrel in healthy Chinese subjects. This study was designed as a single-center, randomized, double-blind, placebo...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Medicine (Baltimore)
Egile Nagusiak: Li, Hui, Chen, Hanjing, Chen, Weili, Xu, Hongrong, Yuan, Fei, Yang, Mengjie, Sun, Hongbin, Yang, Jin, Liu, Yongqiang, Lai, Xiaojuan, Gong, Yanchun, Liu, Xuefang, Li, Yongguo, Sheng, Lei, Liu, Chao, Li, Xuening
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Wolters Kluwer Health 2020
Gaiak:
4200
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7004678/
https://ncbi.nlm.nih.gov/pubmed/31977858
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000018683
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak